Related Experiment Videos
Does negative heparin-platelet factor 4 enzyme-linked immunosorbent assay effectively exclude heparin-induced
Journal of Thrombosis and Haemostasis : JTH
|August 13, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Management of antiplatelet therapy for non elective invasive procedures of bleeding complications: proposals from the French working group on perioperative haemostasis (GIHP), in collaboration with the French Society of Anaesthesia and Intensive Care Medicine (SFAR).
Anaesthesia, critical care & pain medicine·2018
Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.
European journal of neurology·2018
[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013].
Annales francaises d'anesthesie et de reanimation·2013
Successful management of heparin-induced thrombocytopenia using argatroban in a very old woman: a case report.
Case reports in medicine·2013
Prestroke antiplatelet therapy and early prognosis in stroke patients: the Dijon Stroke Registry.
European journal of neurology·2013
Preserving Expertise in Vitamin K Antagonists in the Era of Direct Oral Anticoagulants: Avoiding Therapeutic Segregation.
Journal of thrombosis and haemostasis : JTH·2026
Use of Factor Concentrates for the Management of Perioperative Bleeding: Guidance from the ISTH SSC Subcommittee on Perioperative and Critical Care Thrombosis and Hemostasis.
Journal of thrombosis and haemostasis : JTH·2026
Successful immune tolerance induction using efanesoctocog alfa in severe hemophilia A: A case series.
Journal of thrombosis and haemostasis : JTH·2026
Pretest DOAC removal is highly effective in lupus anticoagulant testing while on direct oral anticoagulants: a real-life experience.
Journal of thrombosis and haemostasis : JTH·2026
The Tissue Factor-TFPI Pathway as a Therapeutic Target in Bleeding Disorders of Unknown Cause.
Journal of thrombosis and haemostasis : JTH·2026
Mathematical Modeling of Flow-Mediated Thrombin Generation after Treatment of Post-Operative Bleeding in Cardiac Surgery with Cardiopulmonary Bypass.
Journal of thrombosis and haemostasis : JTH·2026
Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis: REBOOT-PARADOX.
Journal of the American College of Cardiology·2026
A multicenter prospective observational cohort study to improve diagnostic yield and clinical management of persons with a Bleeding Disorder of Unknown Cause (BDUC-iN study protocol).
Research and practice in thrombosis and haemostasis·2026
Avatrombopag in thrombopoietin receptor agonist-naïve patients with immune thrombocytopenia: real-world treatment patterns and clinical outcomes from the REAL-AVA 3.0 study.
Research and practice in thrombosis and haemostasis·2026
Retraction: Targeted plasmalogen supplementation: effects on blood plasmalogens, oxidative stress biomarkers, cognition, and mobility in cognitively impaired persons.
Frontiers in cell and developmental biology·2026